Layton Maneerat R, Sritanyarat Wanapa, Chadbunchachai Supatra, Wertheimer Albert I
Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand.
Pharm World Sci. 2007 Dec;29(6):619-27. doi: 10.1007/s11096-007-9112-4. Epub 2007 Aug 21.
To determine the sources and the types of information about new drugs that Thai doctors at a teaching hospital perceived as important before prescribing and to assess their views on their preferred sources of drug information.
There were two phases of this study, the quantitative and the qualitative components. For the quantitative study, a descriptive survey using a self-reported questionnaire was mailed. The qualitative component consisted of face-to-face interviews using a semi-structured questionnaire.
The initial sources of information about new drugs; the reliability scores for each source of information; the types of information that doctors required before prescribing new drugs; and the prescribers' views on their preferred sources.
The general findings regarding the doctors' information sources on new drugs were consistent in both the quantitative and qualitative analyses. Conferences, medical journals, and meetings with medical representatives were the initial sources of information for new drugs. Safety and efficacy profiles of new drugs were the most common types of information considered before prescribing new medicines. Although the medical representatives were viewed as very efficient in providing information about new drugs, the interviewees perceived that the information obtained from the persons employed by the pharmaceutical companies was likely to be biased. Consequently, the physicians preferred to have an unbiased resource person who could proactively provide two-sided information for both existing and new drugs at the hospital.
The information sources on new drugs most frequently used by the physicians include scientific conferences, journals and medical representatives and they yearn for unbiased information regarding safety and efficacy of the promoted drugs before prescribing the new medicines. Thus, there is a window of opportunity for hospital pharmacists to serve the unmet needs of the physicians.
确定一家教学医院的泰国医生在开处方前认为重要的新药信息来源和类型,并评估他们对首选药物信息来源的看法。
本研究分为两个阶段,即定量研究和定性研究。定量研究采用自填式问卷进行描述性调查并邮寄。定性研究包括使用半结构化问卷进行面对面访谈。
新药信息的初始来源;每种信息来源的可靠性评分;医生在开新药处方前所需的信息类型;以及开处方者对其首选信息来源的看法。
定量和定性分析中关于医生新药信息来源的总体发现一致。会议、医学期刊以及与医药代表的会面是新药信息的初始来源。新药的安全性和有效性概况是开新药处方前最常考虑的信息类型。尽管医药代表被认为在提供新药信息方面非常高效,但受访者认为从制药公司聘请的人员那里获得的信息可能存在偏差。因此,医生们希望有一个公正的信息提供者,能够主动为医院的现有药物和新药提供全面的信息。
医生最常使用的新药信息来源包括科学会议、期刊和医药代表,他们在开新药处方前渴望获得有关所推广药物安全性和有效性的公正信息。因此,医院药剂师有机会满足医生未满足的需求。